NCT00330200View on ClinicalTrials.gov

Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 1, 2005

Primary Completion Date

March 1, 2007

Study Completion Date

March 1, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ISIS 113715

Trial Locations (1)

06511

Yale - New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY